These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15625142)

  • 1. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
    Nappi C; Di Spiezio Sardo A; Greco E; Tommaselli GA; Giordano E; Guida M
    Obstet Gynecol; 2005 Jan; 105(1):53-60. PubMed ID: 15625142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
    Gargano V; Massaro M; Morra I; Formisano C; Di Carlo C; Nappi C
    Contraception; 2008 Jul; 78(1):10-5. PubMed ID: 18555812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.
    Paoletti AM; Orrù M; Lello S; Floris S; Ranuzzi F; Etzi R; Zedda P; Guerriero S; Fratta S; Sorge R; Mallarini G; Melis GB
    Contraception; 2004 Oct; 70(4):293-8. PubMed ID: 15451333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
    Massaro M; Di Carlo C; Gargano V; Formisano C; Bifulco G; Nappi C
    Contraception; 2010 Mar; 81(3):209-14. PubMed ID: 20159176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure.
    Yildizhan R; Yildizhan B; Adali E; Yoruk P; Birol F; Suer N
    Arch Gynecol Obstet; 2009 Aug; 280(2):255-61. PubMed ID: 19125264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
    Nappi C; Di Spiezio Sardo A; Acunzo G; Bifulco G; Tommaselli GA; Guida M; Di Carlo C
    Contraception; 2003 May; 67(5):355-9. PubMed ID: 12742557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake.
    Endrikat J; Gerlinger C; Cronin M; Wessel J; Ruebig A; Rosenbaum P; Düsterberg B
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):199-204. PubMed ID: 11848649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido.
    Oranratanaphan S; Taneepanichskul S
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S17-22. PubMed ID: 17726807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives.
    Castelo-Branco C; Vicente JJ; Pons F; Martínez de Osaba MJ; Casals E; Vanrell JA
    J Reprod Med; 2001 Oct; 46(10):875-9. PubMed ID: 11725730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: an observational, preliminary study.
    Di Carlo C; Gargano V; Sparice S; Tommaselli GA; Bifulco G; Schettino D; Nappi C
    Eur J Contracept Reprod Health Care; 2013 Oct; 18(5):388-93. PubMed ID: 23859010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
    Gaspard U; Endrikat J; Desager JP; Buicu C; Gerlinger C; Heithecker R
    Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral contraceptive treatment on bone mass acquisition in skeletally immature young female rats.
    Eleftheriades MI; Lambrinoudaki IV; Christodoulakos GE; Gregoriou OV; Economou EV; Kouskouni EE; Antoniou AG; Perrea DN; Dontas IA; Raptou PD; Lyritis GP; Creatsas GC
    Contraception; 2005 May; 71(5):362-71. PubMed ID: 15854638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density.
    Endrikat J; Mih E; Düsterberg B; Land K; Gerlinger C; Schmidt W; Felsenberg D
    Contraception; 2004 Mar; 69(3):179-87. PubMed ID: 14969664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of drospirenone/estrogen combinations on bone metabolism.
    Christiansen C
    Climacteric; 2005 Oct; 8 Suppl 3():35-41. PubMed ID: 16203654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
    Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.
    Oner G; Muderris II
    Contraception; 2011 Nov; 84(5):508-11. PubMed ID: 22018126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol.
    Sørdal T; Grob P; Verhoeven C
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1279-85. PubMed ID: 22762147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.